Menu
Search
|

Menu

Close
X

iRhythm Technologies Inc IRTC.OQ (NASDAQ Stock Exchange Global Select Market)

83.19 USD
-1.53 (-1.81%)
As of Jul 21
chart
Previous Close 84.72
Open 84.79
Volume 48,249
3m Avg Volume 86,109
Today’s High 85.43
Today’s Low 83.16
52 Week High 89.36
52 Week Low 40.19
Shares Outstanding (mil) 22.73
Market Capitalization (mil) 1,152.86
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.25 Mean rating from 8 analysts

KEY STATS

Revenue (mm, USD)
FY18
31
FY17
99
FY16
64
FY15
20
EPS (USD)
FY18
-0.473
FY17
-1.295
FY16
-1.099
FY15
-0.666
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.76
Price to Sales (TTM)
vs sector
14.27
5.73
Price to Book (MRQ)
vs sector
13.10
5.47
Price to Cash Flow (TTM)
vs sector
--
23.29
Total Debt to Equity (MRQ)
vs sector
37.84
16.84
LT Debt to Equity (MRQ)
vs sector
36.16
12.51
Return on Investment (TTM)
vs sector
-31.58
14.61
Return on Equity (TTM)
vs sector
--
16.34

EXECUTIVE LEADERSHIP

Abhijit Talwalkar
Independent Chairman of the Board, Since 2016
Salary: --
Bonus: --
Kevin King
President, Chief Executive Officer, Director, Since 2012
Salary: $456,346.00
Bonus: $585,000.00
Matthew Garrett
Chief Financial Officer, Since 2013
Salary: $280,335.00
Bonus: $195,300.00
David Vort
Executive Vice President of Sales, Since 2014
Salary: $260,262.00
Bonus: $223,550.00
Derrick Sung
Executive Vice President - Strategy and Corporate Development, Since 2015
Salary: $288,577.00
Bonus: $130,500.00

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

650 Townsend St Ste 500
SAN FRANCISCO   CA   94103-6227

Phone: +1415.6325700

iRhythm Technologies, Inc. is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report. Its myZIO provides a way for patients to enter their symptoms as they occur and on-the-go while wearing the ZIO Patch. Its ZIO Event Card is indicated for use on patients who experience transient symptoms, such as syncope, palpitations, and shortness of breath or dizziness. Its ZIO XT Patch is a non-invasive, water-resistant heart monitor, which prompts high patient compliance and a higher diagnostic yield. Its algorithms analyze the amounts of captured heart beat data and a concise report is provided to the patient’s physician. Its ZIO Report produces a higher diagnostic yield and to change patient management.

SPONSORED STORIES